Francesco Cicirello

BioNTech US Inc.
Senior Director, Quality Compliance BioNTainer
Francesco Cicirello is Senior Director, Quality Compliance at BioNTech US.

Before joining BioNTech, Francesco worked in a Regulatory Agency. He was an Expert Inspector at the Therapeutic Good Administration (TGA) in Australia. He was elected to several roles in PIC/S including Chairperson of the Working Group revising the PIC/s Annex 2 and Deputy Chair of the Subcommittee on Harmonisation.

Francesco represented PIC/S at the EMA IWG and was member of the PIC/S Coordinating Committee on the Human Blood, Tissues, Cells & ATMPs.

Related Articles

Advancements in Cell and Gene Therapy Manufacturing
iSpeak Blog
Advancements in Cell and Gene Therapy Manufacturing

In the wake of the COVID-19 pandemic, the landscape of cell and gene therapy (CGT) manufacturing has witnessed significant transformation. The industry has seen an increased emphasis on the advantages of advanced therapy medicinal products (ATMPs) and the push for increases in manufacturing scale and overall availability to larger populations. ATMPs find themselves at a critical juncture where...

Continuous Improvements in ATMPs and Cell & Gene Therapies
iSpeak Blog
Continuous Improvements in ATMPs and Cell & Gene Therapies

ATMPs, Cell and Genetic therapies - or whatever other jurisdictions use – have come a long way. I am unsure how many of us have forgotten the early failures and setbacks. There was a time, in the early years, when serious side effects, such as deaths, endangered the field. It prompted the regulators to halt research, introducing various constraints and safeguards. In Europe, it felt like every...